Cargando…

Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes

Introduction  Traditionally, the concept of complete omentectomy during gastric resection for cancer was based on lymphatic drainage and the occurrence of occult omental metastasis (OM). However, recent emerging evidence has challenged this concept of complete omentectomy. We, therefore, aim to find...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Negine, Surendran, Suraj, Yacob, Myla, Thenmozhi, Mani, Chandran, Sudhakar, Samarasam, Inian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902107/
https://www.ncbi.nlm.nih.gov/pubmed/36756092
http://dx.doi.org/10.1055/s-0042-1751096
_version_ 1784883186217517056
author Paul, Negine
Surendran, Suraj
Yacob, Myla
Thenmozhi, Mani
Chandran, Sudhakar
Samarasam, Inian
author_facet Paul, Negine
Surendran, Suraj
Yacob, Myla
Thenmozhi, Mani
Chandran, Sudhakar
Samarasam, Inian
author_sort Paul, Negine
collection PubMed
description Introduction  Traditionally, the concept of complete omentectomy during gastric resection for cancer was based on lymphatic drainage and the occurrence of occult omental metastasis (OM). However, recent emerging evidence has challenged this concept of complete omentectomy. We, therefore, aim to find the incidence and risk factors of occult OM and also evaluate the outcome of patients with and without such metastasis. Methods  This is a single institutional, retrospective study of patients with gastric cancer who underwent curative radical gastrectomy for a period of 3 years (April 1, 2016, to March 31, 2019). A complete omentectomy was performed in all patients and the omentum and nodal stations were dissected in the resected specimen and sent for pathological analysis. Clinical and epidemiological data were collected from the hospital patient database and analysis was done. Results  A total of 185 patients have been included in the study, with a mean age of 53.84 years. Twenty of the 185 patients had OM (10.8%). Age, sex, location of the tumor, and neoadjuvant chemotherapy were not statistically significant in predicting OM. However, tumor size and tumor depth were found to have a significant association with OM. The occurrence of OM was more likely to be associated with disease recurrence, especially in the peritoneum. The mean overall survival was 38.15 months (±3.33 SD), whereas patients with OM had lower survival, 23.31 months (±7.79 SD), with a p -value of 0.012. Conclusion  OM was not encountered in T1 and T2 gastric cancers and the incidence of OM in T3 and T4 tumors was approximately 12.7%. Therefore, complete omentectomy may be omitted in early T1/T2 tumors. OM was associated with poor prognosis, increased peritoneal recurrence, and decreased overall survival, in spite of a complete omentectomy, and may serve as a prognostic indicator for disease recurrence and overall survival.
format Online
Article
Text
id pubmed-9902107
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-99021072023-02-07 Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes Paul, Negine Surendran, Suraj Yacob, Myla Thenmozhi, Mani Chandran, Sudhakar Samarasam, Inian South Asian J Cancer Introduction  Traditionally, the concept of complete omentectomy during gastric resection for cancer was based on lymphatic drainage and the occurrence of occult omental metastasis (OM). However, recent emerging evidence has challenged this concept of complete omentectomy. We, therefore, aim to find the incidence and risk factors of occult OM and also evaluate the outcome of patients with and without such metastasis. Methods  This is a single institutional, retrospective study of patients with gastric cancer who underwent curative radical gastrectomy for a period of 3 years (April 1, 2016, to March 31, 2019). A complete omentectomy was performed in all patients and the omentum and nodal stations were dissected in the resected specimen and sent for pathological analysis. Clinical and epidemiological data were collected from the hospital patient database and analysis was done. Results  A total of 185 patients have been included in the study, with a mean age of 53.84 years. Twenty of the 185 patients had OM (10.8%). Age, sex, location of the tumor, and neoadjuvant chemotherapy were not statistically significant in predicting OM. However, tumor size and tumor depth were found to have a significant association with OM. The occurrence of OM was more likely to be associated with disease recurrence, especially in the peritoneum. The mean overall survival was 38.15 months (±3.33 SD), whereas patients with OM had lower survival, 23.31 months (±7.79 SD), with a p -value of 0.012. Conclusion  OM was not encountered in T1 and T2 gastric cancers and the incidence of OM in T3 and T4 tumors was approximately 12.7%. Therefore, complete omentectomy may be omitted in early T1/T2 tumors. OM was associated with poor prognosis, increased peritoneal recurrence, and decreased overall survival, in spite of a complete omentectomy, and may serve as a prognostic indicator for disease recurrence and overall survival. Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-08-23 /pmc/articles/PMC9902107/ /pubmed/36756092 http://dx.doi.org/10.1055/s-0042-1751096 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Paul, Negine
Surendran, Suraj
Yacob, Myla
Thenmozhi, Mani
Chandran, Sudhakar
Samarasam, Inian
Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes
title Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes
title_full Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes
title_fullStr Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes
title_full_unstemmed Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes
title_short Occult Omental Metastasis in Gastric Adenocarcinoma: An Analysis of Incidence, Predictors, and Outcomes
title_sort occult omental metastasis in gastric adenocarcinoma: an analysis of incidence, predictors, and outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902107/
https://www.ncbi.nlm.nih.gov/pubmed/36756092
http://dx.doi.org/10.1055/s-0042-1751096
work_keys_str_mv AT paulnegine occultomentalmetastasisingastricadenocarcinomaananalysisofincidencepredictorsandoutcomes
AT surendransuraj occultomentalmetastasisingastricadenocarcinomaananalysisofincidencepredictorsandoutcomes
AT yacobmyla occultomentalmetastasisingastricadenocarcinomaananalysisofincidencepredictorsandoutcomes
AT thenmozhimani occultomentalmetastasisingastricadenocarcinomaananalysisofincidencepredictorsandoutcomes
AT chandransudhakar occultomentalmetastasisingastricadenocarcinomaananalysisofincidencepredictorsandoutcomes
AT samarasaminian occultomentalmetastasisingastricadenocarcinomaananalysisofincidencepredictorsandoutcomes